Registry Describing Clinical Information, Conventional, and Advanced Magnetic Resonance Imaging Information of Patients With Brain Glioma
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
This registry aims to collect clinical and radiologic information including detailed clinical, conventional MR and advanced MR imaging data of patients with brain gliomas. Advanced MR imaging may include diffusion-weighted imaging, perfusion-weighted imaging (dynamic susceptibility contrast, arterial spin labeling, dynamic contrast enhancement), and chemical exchange saturation transfer (CEST) imaging. This registry will describe course of disease and long-term outcomes of brain gliomas.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients must have radiologically and histologically confirmed diagnosis of Brain Glioma
• Life expectancy of greater than 3 months
• Must receive a first- or second-line therapy
• Signed informed consent
Locations
Other Locations
Republic of Korea
Asan Medical Center
RECRUITING
Seoul
Contact Information
Primary
Ho Sung Kim, M.D.,Ph.D.
radhskim@gmail.com
+82230105682
Backup
Ji Eun Park, M.D.
jieunp@gmail.com
+82230101505
Time Frame
Start Date: 2015-09
Estimated Completion Date: 2040-12
Participants
Target number of participants: 9000
Treatments
Patients with glioma requiring treatment
Patients with glioma requiring treatment, who undergo 3-Tesla magnetic resonance imaging to measure tumor protein content (using CEST-MRI), cellularity (using DW-MRI), and perfusion (using DCE-MRI and DSC-MRI with IV administration of gadolinium-containing contrast agent
Related Therapeutic Areas
Sponsors
Leads: Asan Medical Center